Frontiers in immunology · 2025
DEFA5-producing CD4+ T cells in the intestines of atopic dermatitis patients play an important role in the development of AD-associated intestinal inflammation.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhuang Kai, Li Mengjun, Wu Yalan, Luo Yi, Song Jian, Chan Sze Chun Leo, Li Jinmei, Chen Ziying, Ouyang Yulin, Zhang Yongliang, Lin Ying, Luo Huanhuan
Аннотация
RATIONALE: Atopic dermatitis (AD) is associated with various gastrointestinal symptoms, yet the underlying mechanisms remain poorly understood. This study aimed to investigate intraepithelial lymphocytes (IELs) in the intestines of AD patients and their potential contribution to intestinal inflammation.
METHODS: Single-cell RNA sequencing was utilized to analyze the immune cell composition in the ileum of adult AD patients with severe symptoms. Laser confocal microscopy, Western blot, polymerase chain reaction and adoptive T cell transfer experiments were carried out to investigate the phenotypes of IELs and contribution of CD4+ IELs in intestinal inflammation and barrier function.
RESULTS: A distinct group of DEFA5-expressing CD4+ T cells in the small intestine of AD patients was identified. These cells were enriched in tissue resident memory T cells (Trm). Peroxisome proliferator-activated receptor (PPAR) was found to be important for the function of DEFA5-expression CD4+ IELs. In an AD mouse model, an increase in DEFA5-expressing CD4+ IELs was observed compared to control, and these cells contributed to the development of intestinal inflammation and impaired intestinal barrier function.
CONCLUSIONS: AD is linked to an increase in intestinal DEFA5-expressing CD4+ IELs, which may play an important role in mediating intestinal inflammation. This suggests that the DEFA5-expressing CD4+ IELs could be a potential therapeutic target for managing gastrointestinal symptoms in AD patients.
METHODS: Single-cell RNA sequencing was utilized to analyze the immune cell composition in the ileum of adult AD patients with severe symptoms. Laser confocal microscopy, Western blot, polymerase chain reaction and adoptive T cell transfer experiments were carried out to investigate the phenotypes of IELs and contribution of CD4+ IELs in intestinal inflammation and barrier function.
RESULTS: A distinct group of DEFA5-expressing CD4+ T cells in the small intestine of AD patients was identified. These cells were enriched in tissue resident memory T cells (Trm). Peroxisome proliferator-activated receptor (PPAR) was found to be important for the function of DEFA5-expression CD4+ IELs. In an AD mouse model, an increase in DEFA5-expressing CD4+ IELs was observed compared to control, and these cells contributed to the development of intestinal inflammation and impaired intestinal barrier function.
CONCLUSIONS: AD is linked to an increase in intestinal DEFA5-expressing CD4+ IELs, which may play an important role in mediating intestinal inflammation. This suggests that the DEFA5-expressing CD4+ IELs could be a potential therapeutic target for managing gastrointestinal symptoms in AD patients.